BACKGROUND: Tuberculosis (TB) is a chronic wasting inflammatory disease characterized by multisystem involvement, which can cause metabolic derangements in afflicted patients. Metabolic signatures have been exploited in the study of several diseases. However, the serum that is successfully used in TB diagnosis on the basis of metabolic profiling is not by much. METHODS: Orthogonal partial least-squares discriminant analysis was capable of distinguishing TB patients from both healthy subjects and patients with conditions other than TB. Therefore, TB-specific metabolic profiling was established. Clusters of potential biomarkers for differentiating TB active from non-TB diseases were identified using Mann-Whitney U-test. Multiple logistic regression analysis of metabolites was calculated to determine the suitable biomarker group that allows the efficient differentiation of patients with TB active from the control subjects. RESULTS: From among 271 participants, 12 metabolites were found to contribute to the distinction between the TB active group and the control groups. These metabolites were mainly involved in the metabolic pathways of the following three biomolecules: Fatty acids, amino acids, and lipids. The receiver operating characteristic curves of 3D, 7D, and 11D-phytanic acid, behenic acid, and threoninyl-γ-glutamate exhibited excellent efficiency with area under the curve (AUC) values of 0.904 (95% confidence interval [CI]: 0863-0.944), 0.93 (95% CI: 0.893-0.966), and 0.964 (95% CI: 00.941-0.988), respectively. The largest and smallest resulting AUCs were 0.964 and 0.720, indicating that these biomarkers may be involved in the disease mechanisms. The combination of lysophosphatidylcholine (18:0), behenic acid, threoninyl-γ-glutamate, and presqualene diphosphate was used to represent the most suitable biomarker group for the differentiation of patients with TB active from the control subjects, with an AUC value of 0.991. CONCLUSION: The metabolic analysis results identified new serum biomarkers that can distinguish TB from non-TB diseases. The metabolomics-based analysis provides specific insights into the biology of TB and may offer new avenues for TB diagnosis.
BACKGROUND:Tuberculosis (TB) is a chronic wasting inflammatory disease characterized by multisystem involvement, which can cause metabolic derangements in afflicted patients. Metabolic signatures have been exploited in the study of several diseases. However, the serum that is successfully used in TB diagnosis on the basis of metabolic profiling is not by much. METHODS: Orthogonal partial least-squares discriminant analysis was capable of distinguishing TB patients from both healthy subjects and patients with conditions other than TB. Therefore, TB-specific metabolic profiling was established. Clusters of potential biomarkers for differentiating TB active from non-TB diseases were identified using Mann-Whitney U-test. Multiple logistic regression analysis of metabolites was calculated to determine the suitable biomarker group that allows the efficient differentiation of patients with TB active from the control subjects. RESULTS: From among 271 participants, 12 metabolites were found to contribute to the distinction between the TB active group and the control groups. These metabolites were mainly involved in the metabolic pathways of the following three biomolecules: Fatty acids, amino acids, and lipids. The receiver operating characteristic curves of 3D, 7D, and 11D-phytanic acid, behenic acid, and threoninyl-γ-glutamate exhibited excellent efficiency with area under the curve (AUC) values of 0.904 (95% confidence interval [CI]: 0863-0.944), 0.93 (95% CI: 0.893-0.966), and 0.964 (95% CI: 00.941-0.988), respectively. The largest and smallest resulting AUCs were 0.964 and 0.720, indicating that these biomarkers may be involved in the disease mechanisms. The combination of lysophosphatidylcholine (18:0), behenic acid, threoninyl-γ-glutamate, and presqualene diphosphate was used to represent the most suitable biomarker group for the differentiation of patients with TB active from the control subjects, with an AUC value of 0.991. CONCLUSION: The metabolic analysis results identified new serum biomarkers that can distinguish TB from non-TB diseases. The metabolomics-based analysis provides specific insights into the biology of TB and may offer new avenues for TB diagnosis.
Authors: B S Somashekar; Anita G Amin; Christopher D Rithner; JoLynn Troudt; Randall Basaraba; Angelo Izzo; Dean C Crick; Delphi Chatterjee Journal: J Proteome Res Date: 2011-07-26 Impact factor: 4.466
Authors: Karsten Suhre; Henri Wallaschofski; Johannes Raffler; Nele Friedrich; Robin Haring; Kathrin Michael; Christina Wasner; Alexander Krebs; Florian Kronenberg; David Chang; Christa Meisinger; H-Erich Wichmann; Wolfgang Hoffmann; Henry Völzke; Uwe Völker; Alexander Teumer; Reiner Biffar; Thomas Kocher; Stephan B Felix; Thomas Illig; Heyo K Kroemer; Christian Gieger; Werner Römisch-Margl; Matthias Nauck Journal: Nat Genet Date: 2011-05-15 Impact factor: 38.330
Authors: J D McKinney; K Höner zu Bentrup; E J Muñoz-Elías; A Miczak; B Chen; W T Chan; D Swenson; J C Sacchettini; W R Jacobs; D G Russell Journal: Nature Date: 2000-08-17 Impact factor: 49.962
Authors: Carolyn M Slupsky; Kathryn N Rankin; Hao Fu; David Chang; Brian H Rowe; Patrick G P Charles; Allison McGeer; Donald Low; Richard Long; Dennis Kunimoto; Michael B Sawyer; Richard N Fedorak; Darryl J Adamko; Erik J Saude; Sirish L Shah; Thomas J Marrie Journal: J Proteome Res Date: 2009-12 Impact factor: 4.466
Authors: Shu-Chun Chuang; Anouar Fanidi; Per Magne Ueland; Caroline Relton; Oivind Midttun; Stein Emil Vollset; Marc J Gunter; Michael J Seckl; Ruth C Travis; Nicholas Wareham; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Petra H M Peeters; H Bas Bueno-de-Mesquita; Heiner Boeing; Angelika Wientzek; Tilman Kuehn; Rudolf Kaaks; Rosario Tumino; Claudia Agnoli; Domenico Palli; Alessio Naccarati; Eva Ardanaz Aicua; María-José Sánchez; José Ramón Quirós; María-Dolores Chirlaque; Antonio Agudo; Mikael Johansson; Kjell Grankvist; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Guy Fagherazzi; Elisabete Weiderpass; Elio Riboli; Paul J Brennan; Paolo Vineis; Mattias Johansson Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-12-19 Impact factor: 4.254
Authors: Yi Ding; Robert-Jan Raterink; Rubén Marín-Juez; Wouter J Veneman; Koen Egbers; Susan van den Eeden; Mariëlle C Haks; Simone A Joosten; Tom H M Ottenhoff; Amy C Harms; A Alia; Thomas Hankemeier; Herman P Spaink Journal: Sci Rep Date: 2020-07-15 Impact factor: 4.379
Authors: January Weiner; Jeroen Maertzdorf; Jayne S Sutherland; Fergal J Duffy; Ethan Thompson; Sara Suliman; Gayle McEwen; Bonnie Thiel; Shreemanta K Parida; Joanna Zyla; Willem A Hanekom; Robert P Mohney; W Henry Boom; Harriet Mayanja-Kizza; Rawleigh Howe; Hazel M Dockrell; Tom H M Ottenhoff; Thomas J Scriba; Daniel E Zak; Gerhard Walzl; Stefan H E Kaufmann Journal: Nat Commun Date: 2018-12-06 Impact factor: 14.919